Projects

Clinical Outcome and Pathologic Response after Neo-Adjuvant Chemoradiation in locally advanced Rectal Cancers – A Prospective and Retrospective Observational Study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2017 - 2021

Project Lead

Avinash H Udayashankara

Authors

Avinash H Udayashankara, Anuradha Ananthamurthy, Nirmala S

Project Status

completed

Project Type

Prospective